Drug intelligence / Profile preview

Salcol

Development stage
Unknown
Lead developer
Amdis Healthsciences
Modality
Recombinant Proteins and Enzymes
Administration
Oral
01

Overview

Salcol is a nutraceutical product developed and marketed by Amdis Healthsciences, primarily indicated for the management of joint pain and osteoarthritis. Its primary active ingredient is **undenatured collagen type II (UC-II)**, a protein derived from chicken sternum cartilage. Unlike denatured collagen, UC-II maintains its biological activity and works through a mechanism known as oral tolerance. Upon ingestion, it interacts with Peyer's patches in the gut-associated lymphoid tissue (GALT), triggering the production of regulatory T cells (Tregs) that migrate to the joints and release anti-inflammatory cytokines like IL-10 and TGF-beta. This process helps to suppress the immune-mediated destruction of articular cartilage and promotes joint repair and mobility.

Brand names
Salcol
Other names
Undenatured Collagen Type IIUC-II

Beyond the preview

Go deeper on Salcol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Salcol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call